Cellect Biotechnology Ltd. - ADR
APOP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.07M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.07 Million |
|---|---|
| Enterprise Value | $-2,059,281.00 |
| Earnings per Share | $-1642266.42 |
| Beta | 1.88 |
| Outstanding Shares | 80,884 |
Return
| Return on Equity | -180161.89% |
|---|---|
| Return on Assets | -100719.75% |
| Return on Invested Capital | 38.16% |
Valuation & Multiples
| P/E Ratio | -0.3 |
|---|---|
| PEG | -0.98 |
| Price to Sales | - |
| Price to Book Ratio | 0.12 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 31.89 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.00% |
|---|---|
| Total Invested | $6 |
| Investors Holding | 10% |
About Cellect Biotechnology Ltd.
CEO: Shai Yarkoni
